Summary of Classification and Labelling
Harmonised classification - Annex VI of Regulation (EC) No 1272/2008 (CLP Regulation)
General Information
Index Number EC / List no.

EC: European Community number/ List no.: List number assigned by ECHA.

List Numbers are purely technical identifiers for processing a submission via REACH-IT. More information: https://echa.europa.eu/information-on-chemicals/registered-substances/information

CAS Number International Chemical Identification
007-004-00-1 231-714-2 7697-37-2 nitric acid ... %

ATP Inserted / Updated: CLP00/ATP07 This field indicates when an entry in Annex VI to CLP has been inserted and/or updated with an Adaptation to Technical Progress (ATP) to the CLP Regulation.
CLP Classification (Table 3)
Classification Labelling Specific Concentration limits, M-Factors, Acute Toxicity Estimates (ATE) Notes
Hazard Class and Category Code(s) Hazard Statement Code(s) Hazard Statement Code(s) Supplementary Hazard Statement Code(s) Pictograms, Signal Word Code(s)
Ox. Liq. 2 H272 H272 EUH071
GHS03
GHS05
Dgr
Ox. Liq. 2; H272: C ≥ 99 %
Ox. Liq. 3; H272: 65 % ≤ C < 99 %
Skin Corr. 1A; H314: C ≥ 20 %
Skin Corr. 1B; H314: 5 % ≤ C < 20 %
Note B
Skin Corr. 1A H314 H314

Signal Words Pictograms
Danger
GHS03
Flame over circle
GHS05
Corrosion
Seveso III Data
Disclaimer: Please note that some of the substances covered by the Seveso Directive can belong to more than one Seveso categories. It will be up to the users to decide whether their substance or mixture fall in one or in more of these classification categories depending on the tonnage bands and the concentrations.
Please also note that ECHA is not an authority for the Seveso Directive and that the Seveso categorisation below is provided for information only. The Seveso III Directive (Directive 2012/18/EU repealing Directive 96/82/EC (Seveso II) from 1 June 2015) is the only authentic legal reference and that the information in this inventory does not constitute legal advice. For further information on Seveso, please ask your national authority.

Seveso Data
Seveso Substance Seveso Categories
Tak P8
Notified classification and labelling
General Information
EC / List no.

EC: European Community number/ List no.: List number assigned by ECHA.

List Numbers are purely technical identifiers for processing a submission via REACH-IT. More information: https://echa.europa.eu/information-on-chemicals/registered-substances/information

Name CAS Number
The CAS number associated with this substance in the EC Inventory and/or REACH-IT is reported here. In some cases, e.g. for differently hydrated forms of the same substance, alternative CAS numbers have been notified. In those cases, the additional CAS numbers are published in the column “additional notified information” below.
231-714-2 Nitric acid 7697-37-2

Notified classification and labelling according to CLP criteria
Classification Labelling Specific Concentration limits, M-Factors Notes Classification affected by Impurities / Additives

This check appears when a notifier has indicated that an impurity or an additive present in the substance impacts the notified classification. ECHA cannot reveal the identity of the impurity/additive or determine the exact impact it has on the classification.

Additional Notified Information

State/form: The notified state/form of the substance for all notifications classifying in this manner is reported under this link. Additional CAS number(s): Occasionally, a notification contains a different CAS number than the one reported under the general information section above. In those cases, all different notified CAS numbers associated with the aggregated classification are reported under this link. IUPAC name(s): Publicly available IUPAC names from all notifications classifying in this manner are reported under this link.

Number of Notifiers

This number indicates how many companies notified this classification. All members of a REACH registration joint submission and all participants in a group of manufacturers/importers who notified are counted. The grouping is done automatically with no manual verification.

Joint Entries

This check appears when a classification comes from a lead dossier of a REACH registration joint submission. When a member submits a classification separately under Article 11(3) of REACH (opt-out), this classification is displayed separately and not marked as a joint entry.

Hazard Class and Category Code(s) Hazard Statement Code(s) Hazard Statement Code(s) Supplementary Hazard Statement Code(s) Pictograms, Signal Word Code(s)
H272 H272 EUH071
GHS03
GHS05
GHS06
Dgr
Skin Corr. 1A; : C ≥ 20 %
Ox. Liq. 3; : 65 % ≤ C < 99 %
Ox. Liq. 2; : C ≥ 99 %
Skin Corr. 1B; : 5 % ≤ C < 20 %
Note B
State/Form
IUPAC Names
79 yes View details
Met. Corr. 1 H290 H290
Skin Corr. 1A H314 H314
Acute Tox. 3 H331 H331
H272 H272 GHS03
GHS05
Dgr
Note B
State/Form
IUPAC Names
1017 View details
Skin Corr. 1A H314 H314
H272 H272 GHS03
GHS05
Dgr
Ox. Liq. 3; : C ≥ 65 %
Skin Corr. 1A; : C ≥ 20 %
Skin Corr. 1B; : 5 % ≤ C < 20 %
Note B
State/Form
IUPAC Names
483 View details
Skin Corr. 1A H314 H314
Ox. Liq. 2 H272 H272 EUH071
GHS03
GHS05
Dgr
Ox. Liq. 3; : 65 % ≤ C < 99 %
Skin Corr. 1A; : C ≥ 20 %
Skin Corr. 1B; : 5 % ≤ C < 20 %
Ox. Liq. 2; : C ≥ 99 %
State/Form
IUPAC Names
362 View details
Skin Corr. 1A H314 H314
H272 H272 EUH071
GHS03
GHS05
GHS06
Dgr
Ox. Liq. 2; : C ≥ 99 %
Skin Corr. 1A; : C ≥ 20 %
Ox. Liq. 3; : 65 % ≤ C < 99 %
Skin Corr. 1B; : 5 % ≤ C < 20 %
State/Form
IUPAC Names
66 View details
Met. Corr. 1 H290 H290
Skin Corr. 1A H314 H314
Eye Dam. 1 H318 H318
Acute Tox. 3 H331 H331
H272 H272 GHS03
GHS05
Dgr
State/Form
IUPAC Names
61 View details
Skin Corr. 1A H314 H314
H272 H272 EUH071
GHS03
GHS05
Dgr
Met. Corr. 1; : C ≥ 65 %
Ox. Liq. 3; : C ≥ 65 %
Skin Corr. 1A; : 20 % ≤ C ≤ 65 %
Met. Corr. 1; : 20 % ≤ C ≤ 65 %
Skin Corr. 1B; : 5 % ≤ C < 20 %
Skin Corr. 1A; : C ≥ 65 %
Note B
State/Form
IUPAC Names
47 View details
Met. Corr. 1 H290 H290
Skin Corr. 1A H314 H314
H272 H272 GHS03
GHS05
Dgr
Skin Corr. 1B; : 5 % ≤ C < 20 %
Skin Corr. 1A; : C ≥ 20 %
Ox. Liq. 3; : C ≥ 65 %
State/Form
IUPAC Names
43 View details
Skin Corr. 1A H314 H314
H272 H272 EUH071
GHS03
GHS05
GHS06
Dgr
Ox. Liq. 3; : 65 % ≤ C < 99 %
Ox. Liq. 2; : C ≥ 99 %
Skin Corr. 1B; : 5 % ≤ C < 20 %
Skin Corr. 1A; : C ≥ 20 %
IUPAC Names 30 View details
Met. Corr. 1 H290 H290
Skin Corr. 1A H314 H314
Acute Tox. 3 H331 H331
  H271 Dgr
Ox. Liq. 3; : C ≥ 65 %
Skin Corr. 1B; : 5 % ≤ C < 20 %
Skin Corr. 1A; : C ≥ 20 %
24 View details
  H314
H272 H272 GHS03
GHS05
Dgr
Met. Corr. 1; : C ≥ 20 %
Skin Corr. 1B; : 5 % ≤ C < 20 %
Ox. Liq. 3; : C ≥ 65 %
Skin Corr. 1A; : C ≥ 20 %
Note B
State/Form
IUPAC Names
19 View details
Met. Corr. 1 H290 H290
Skin Corr. 1A H314 H314
H272 H272 GHS03
GHS05
GHS06
Dgr
Skin Corr. 1B; : 5 % ≤ C < 20 %
Skin Corr. 1A; : C ≥ 20 %
Ox. Liq. 3; : C ≥ 65 %
State/Form
IUPAC Names
19 View details
Met. Corr. 1 H290 H290
Skin Corr. 1A H314 H314
Acute Tox. 3 H331 H331
H272 H272 GHS09
GHS03
GHS05
GHS06
GHS07
Dgr
15 View details
Met. Corr. 1 H290 H290
Skin Corr. 1A H314 H314
Eye Dam. 1 H318 H318
Acute Tox. 1 H330 H330
  H335
H272 H272 GHS03
GHS05
Dgr
Skin Corr. 1A; : C ≥ 20 %
Ox. Liq. 3; : C ≥ 65 %
Skin Corr. 1B; : 5 % ≤ C < 20 %
State/Form
13 View details
Ox. Liq. 3 H272 H272
Skin Corr. 1A H314 H314
H272 H272 EUH071
GHS03
GHS05
Dgr
Ox. Liq. 2; : C ≥ 99 %
Skin Corr. 1A; : C ≥ 20 %
Skin Corr. 1B; : 5 % ≤ C < 20 %
Ox. Liq. 3; : 65 % ≤ C < 99 %
State/Form
IUPAC Names
11 View details
Skin Corr. 1A H314 H314
Flam. Liq. 2 H225 H225 GHS02
GHS08
GHS07
Dgr
IUPAC Names 10 View details
Skin Irrit. 2 H315 H315
Eye Irrit. 2 H319 H319
  H335
STOT SE 3 H336 H336
Repr. 1B H360 (FD) H360 (FD)
STOT RE 2 H373 H373
H272 H272 GHS03
GHS05
Dgr
Skin Corr. 1A; : C ≥ 20 %
Ox. Liq. 3; : C ≥ 65 %
Skin Corr. 1B; : 5 % ≤ C < 20 %
Note B
State/Form
IUPAC Names
10 View details
Ox. Liq. 3 H272 H272
Skin Corr. 1A H314 H314
H272 H272 EUH071
GHS03
GHS05
GHS06
Dgr
Skin Corr. 1B; : 5 % ≤ C < 20 %
Skin Corr. 1A; : C ≥ 20 %
Ox. Liq. 3; : C ≥ 65 %
IUPAC Names 10 View details
Met. Corr. 1 H290 H290
Skin Corr. 1A H314 H314
Acute Tox. 3 H331 H331
Skin Corr. 1B H314 H314 GHS05
Dgr
State/Form
IUPAC Names
7 View details
H272 H272 GHS03
GHS05
Dgr
Ox. Liq. 3; : C ≥ 65 %
Skin Corr. 1B; : 5 % ≤ C < 20 %
Skin Corr. 1A; : C ≥ 20 %
Note B
yes State/Form
IUPAC Names
6 View details
Skin Corr. 1A H314 H314
H272 H272 GHS03
GHS05
GHS06
Dgr
Ox. Liq. 3; : C ≥ 65 %
Skin Corr. 1B; : 5 % ≤ C < 20 %
Skin Corr. 1A; : C ≥ 20 %
State/Form
5 View details
Met. Corr. 1 H290 H290
Skin Corr. 1A H314 H314
Acute Tox. 2 H330 H330
H272 H272 GHS03
GHS08
GHS05
Dgr
4 View details
Skin Corr. 1A H314 H314
Eye Dam. 1 H318 H318
STOT SE 1 H370 (Respiratory tra...) (Inhalation) H370 (I)
H272 H272 (H272) GHS03
GHS05
Dgr
Note B
IUPAC Names 4 View details
Skin Corr. 1A H314 H314 (H314)
H272 H272 GHS03
GHS05
Dgr
Ox. Liq. 3; : C ≥ 65 %
Skin Corr. 1B; : C ≥ 5 %
Skin Corr. 1A; : C ≥ 20 %
Note B
State/Form
4 View details
Skin Corr. 1A H314 H314
H272 H272 EUH071
GHS03
GHS05
Dgr
Skin Corr. 1B; : 5 % ≤ C < 20 %
Met. Corr. 1; : C ≥ 5 %
Ox. Liq. 3; : C ≥ 65 %
Skin Corr. 1A; : C ≥ 20 %
Note B
State/Form
IUPAC Names
3 View details
Met. Corr. 1 H290 H290
Skin Corr. 1A H314 H314
Skin Corr. 1A H314 H314 GHS05
Dgr
Skin Corr. 1A; : C ≥ 20 %
Skin Corr. 1B; : C ≥ 5 %
Ox. Liq. 3; : C ≥ 65 %
Note B
State/Form
2 View details
H272 H272 GHS03
GHS05
Dgr
Ox. Liq. 3; : C ≥ 65 %
Skin Corr. 1B; : 5 % ≤ C < 20 %
Skin Corr. 1A; : C ≥ 20 %
Note B
State/Form
IUPAC Names
2 View details
  H290
Skin Corr. 1A H314 H314
H272 H272 EUH071
GHS03
GHS05
GHS06
Dgr
Met. Corr. 1; : C ≥ .2 %
Skin Corr. 1A; : C ≥ 20 %
Skin Corr. 1B; : 5 % ≤ C < 20 %
Ox. Liq. 3; : 65 % ≤ C < 99 %
Ox. Liq. 2; : C ≥ 99 %
Note B
State/Form
IUPAC Names
2 View details
Met. Corr. 1 H290 H290
Skin Corr. 1A H314 H314
Eye Dam. 1 H318  
Acute Tox. 3 H331 H331
H272 H272 GHS03
GHS05
Dgr
Skin Corr. 1A; : C ≥ 20 %
Skin Corr. 1B; : 5 % ≤ C < 20 %
Ox. Liq. 3; : C ≥ 65 %
Note B
State/Form
IUPAC Names
1 View details
Met. Corr. 1 H290  
Skin Corr. 1A H314 H314
Eye Dam. 1 H318 H318
Not Classified               1  
H272 H272 EUH071
GHS03
GHS05
Dgr
Skin Corr. 1A; : C ≥ 20 %
Skin Corr. 1B; : 5 % ≤ C < 20 %
Ox. Liq. 3; : C ≥ 65 %
Note B
Note 1
Note 2
State/Form
IUPAC Names
1 View details
Met. Corr. 1 H290 H290
Acute Tox. 4 H302  
Skin Corr. 1A H314 H314
Acute Tox. 1 H330 H330 GHS06
Dgr
State/Form
IUPAC Names
1 View details
H271 H271 GHS03
Dgr
State/Form
IUPAC Names
1 View details
H272 H272 GHS03
GHS05
Dgr
Ox. Liq. 3; : 65 % ≤ C < 100 %
Skin Corr. 1B; : 5 % ≤ C < 20 %
Skin Corr. 1A; : 20 % ≤ C < 100 %
Note B
1 View details
Skin Corr. 1A H314 H314
Met. Corr. 1 H290 H290 GHS08
GHS05
GHS06
Dgr
State/Form
IUPAC Names
1 View details
Asp. Tox. 1 H304 H304
Skin Corr. 1B H314 H314
Eye Dam. 1 H318 H318
Acute Tox. 2 H330 H330
STOT SE 1 H370 (Respiratory Sys...) H370
STOT RE 1 H372 (Respiratory Sys...) H372
H272 H272 EUH071
GHS03
GHS05
Dgr
Skin Corr. 1A; : C ≥ 20 %
Ox. Liq. 3; : C ≥ 65 %
Skin Corr. 1B; : 5 % ≤ C < 20 %
Note B
State/Form
IUPAC Names
1 View details
Met. Corr. 1 H290 H290
Skin Corr. 1A H314 H314
H272 H272 EUH071
GHS03
GHS05
Dgr
Skin Corr. 1B; : 5 % ≤ C ≤ 20 %
Skin Corr. 1A; : C ≥ 20 %
Ox. Liq. 3; : C ≥ 65 %
State/Form
IUPAC Names
1 View details
Met. Corr. 1 H290 H290
Skin Corr. 1A H314 H314
H272 H272 GHS03
GHS05
Dgr
Skin Corr. 1A; : C > 20 %
Note B
State/Form
IUPAC Names
1 View details
Skin Corr. 1A H314 H314
H272 H272 EUH071
GHS03
GHS05
GHS06
Dgr
Ox. Liq. 3; : C ≥ 65 %
Skin Corr. 1A; : C ≥ 20 %
Skin Corr. 1B; : 5 % ≤ C < 20 %
Note B
State/Form
IUPAC Names
1 View details
Met. Corr. 1 H290 H290
Acute Tox. 4 H302 H302
Skin Corr. 1A H314 H314
Eye Dam. 1 H318  
Acute Tox. 1 H330 H330
H272 H272 GHS05
GHS07
Dgr
State/Form
1 View details
Skin Corr. 1A H314 H314
  H272 (H314) GHS03
GHS05
Dgr
State/Form
1 View details
Skin Corr. 1A H314 H314 GHS05
Dgr
State/Form
1 View details
H272 H272 GHS03
GHS05
Dgr
Ox. Liq. 3; : C ≥ 65 %
Skin Corr. 1A; : C ≥ 20 %
Skin Corr. 1B; : 5 % ≤ C < 20 %
Note B
State/Form
IUPAC Names
1 View details
Met. Corr. 1 H290  
Skin Corr. 1A H314 H314
H272 H272 GHS03
GHS05
Dgr
State/Form
1 View details
Met. Corr. 1 H290 H290
Skin Corr. 1A H314 H314
Eye Dam. 1 H318  
H272 H272 EUH071
GHS03
GHS05
Dgr
Ox. Liq. 2; : C ≥ 99 %
Skin Corr. 1B; : 5 % ≤ C < 20 %
Ox. Liq. 3; : 65 % ≤ C < 99 %
Skin Corr. 1A; : C ≥ 20 %
IUPAC Names 1 View details
Skin Corr. 1A H314 H314
Eye Dam. 1 H318 H318
H272 H272 EUH071
GHS03
GHS05
GHS06
Dgr
Skin Corr. 1A; : C ≥ 20 %
Ox. Liq. 2; : C ≥ 99 %
Skin Corr. 1B; : 5 % ≤ C < 20 %
Ox. Liq. 3; : 65 % ≤ C < 99 %
IUPAC Names 1 View details
Skin Corr. 1A H314 H314
Acute Tox. 3 H331 H331
H272 H272 EUH071
GHS03
GHS05
GHS07
Dgr
Skin Corr. 1A; : C ≥ 20 %
Ox. Liq. 3; : 65 % ≤ C < 99 %
Skin Corr. 1B; : 5 % ≤ C < 20 %
Ox. Liq. 2; : C ≥ 99 %
State/Form
IUPAC Names
1 View details
Skin Corr. 1A H314 H314
  H315
  H319
Ox. Liq. 2 H272 H272 EUH071
GHS03
GHS05
Dgr
Skin Corr. 1B; : 5 % ≤ C < 20 %
Skin Corr. 1A; : C ≥ 20 %
Ox. Liq. 3; : 65 % ≤ C < 99 %
Ox. Liq. 2; : C ≥ 99 %
1 View details
Met. Corr. 1 H290 H290
Skin Corr. 1A H314 H314
Ox. Liq. 2 H272 H272 EUH071
GHS03
GHS05
GHS06
Dgr
Ox. Liq. 3; : 65 % ≤ C < 99 %
Skin Corr. 1A; : C ≥ 20 %
Skin Corr. 1B; : 5 % ≤ C < 20 %
Ox. Liq. 2; : C ≥ 99 %
1 View details
Met. Corr. 1 H290 H290
Skin Corr. 1A H314 H314
Acute Tox. 3 H331 H331

Number of Aggregated Notifications: 49